Do Traders Think Organogenesis Holdings Inc (ORGO) Can Keep Climbing Thursday?

Overall market sentiment has been high on Organogenesis Holdings Inc (ORGO) stock lately. ORGO receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Organogenesis Holdings Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ORGO!

See Full ORGO Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With ORGO Stock Today?

Organogenesis Holdings Inc (ORGO) stock is trading at $3.20 as of 11:17 AM on Thursday, Sep 28, a gain of $0.55, or 20.69% from the previous closing price of $2.65. The stock has traded between $2.91 and $3.34 so far today. Volume today is elevated. So far 1,575,554 shares have traded compared to average volume of 664,480 shares.

More About Organogenesis Holdings Inc

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others. Click Here to get the full Stock Report for Organogenesis Holdings Inc stock.